InflaRx N.V. (IFRX)
NASDAQ: IFRX · Real-Time Price · USD
1.040
-0.050 (-4.59%)
At close: Jan 9, 2026, 4:00 PM EST
1.090
+0.050 (4.81%)
After-hours: Jan 9, 2026, 7:56 PM EST

Revenue by Product

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023
Period Ending
Dec '24 Dec '23
Novel Therapeutic Products
179.33K
Log In
Novel Therapeutic Products Growth
162.93%
Log In

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023
Period Ending
Dec '24 Dec '23
United States
179.33K
Log In
United States Growth
162.93%
Log In